Product
rhTPO combined with Herombopag + CsA
1 clinical trial
2 indications
Indication
Aplastic AnemiaIndication
Drug EffectClinical trial
A Prospective, Randomized, Controlled Study of rhTPO in Combination With Herombopag + CsA vs Herombopag + CsA for the Treatment of Primary Transfusion-dependent NSAAStatus: Not yet recruiting, Estimated PCD: 2024-08-01